Exacerbations of COPD accelerate lung-function loss

May 16, 2016

Exacerbations of chronic obstructive pulmonary disease (COPD) accelerate the loss of lung function especially among patients with mild disease, according to researchers at National Jewish Health and other institutions. Barry Make, MD, professor of medicine at National Jewish Health and his colleagues in the COPDGene study presented their findings at the 2016 American Thoracic Society International Meeting in San Francisco.

"These findings confirm our suspicions that exacerbations of COPD accelerate lung-function loss," said Dr. Make, senior author of the study. "The surprise is that patients with mild disease suffer the greatest loss."

The researchers analyzed data from 2,000 current or former smokers who had been followed for five years as part of the COPDGene study. Thirty-five percent of the study subjects had experienced at least one exacerbation or acute respiratory event requiring antibiotics, oral steroids and/or hospitalization.

Lung function was measured as the amount of air a person can forcefully exhale in one second (FEV1). Exacerbations were associated with additional decline in FEV1 in COPD patients beyond losses due to aging and COPD without exacerbations. The effect was especially prominent among patients with mild COPD, known as GOLD 1. Exacerbations requiring oral steroids or antibiotics resulted in an additional 21 milliliters of lost lung function per year. Exacerbations requiring hospitalization more than tripled that consequence to 75 milliliters per year, by far the largest loss of lung function among any group of COPD patients. Study participants who did not have COPD experienced no additional lung-function loss following exacerbations.

"These findings indicate that patients with mild COPD are particularly susceptible to lung-function loss following exacerbations," said Dr. Make. "We need to include more patients with mild COPD in our clinical trials to potentially reduce the risk of advancing to more severe lung disease."
-end-


National Jewish Health

Related COPD Articles from Brightsurf:

Promising therapeutic approach against COPD
Chronic obstructive pulmonary disease (COPD) is one of the most common and deadliest diseases worldwide.

COPD underdiagnosed in older adults, but can be managed
''Recognizing and Treating COPD in Older Adults'' the latest issue of the What's Hot newsletter from The Gerontological Society of America, addresses what is known about the prevalence, incidence, and impact of chronic obstructive pulmonary disease (COPD) in older adults.

Undersized airways may explain why nonsmokers get COPD
A mismatch between airway and lung size may explain why some nonsmokers get COPD and some heavy smokers do not, according to a new study from Columbia University Irving Medical Center.

Is pulmonary rehab after hospitalization for COPD associated with better survival?
Claims data for nearly 200,000 Medicare patients were used to examine the association between starting pulmonary rehabilitation within 90 days of being hospitalized for chronic obstructive pulmonary disease (COPD) and survival after one year.

COPD and smoking associated with higher COVID-19 mortality
Current smokers and people with chronic obstructive pulmonary disease (COPD) have an increased risk of severe complications and higher mortality with COVID-19 infection, according to a new study published May 11, 2020 in the open-access journal PLOS ONE by Jaber Alqahtani of University College London, UK, and colleagues.

COPD as a lung stem cell disease
Two internationally renowned stem cell researchers at the University of Houston have found an abundance of abnormal stem cells in the lungs of patients who suffer from Chronic Obstructive Pulmonary Disease (COPD), a leading cause of death worldwide.

New hope for COPD patients possible with in-home device
In a new paper published Feb. 4 in JAMA, Mayo Clinic researchers describe the benefits of in-home noninvasive ventilation therapy, which includes a type referred to as bilevel positive airway pressure, or BiPAP -- for many patients with chronic obstructive pulmonary disease (COPD).

COPD appears to cause more severe symptoms in women
Women who develop COPD report smoking fewer cigarettes than men; and yet, women experience greater breathing impairments, are subjected to more acute exacerbations of symptoms and report lower quality of life than men with the disease, according to research presented at ATS 2019.

African-Americans with COPD appear less likely to use pulmonary rehab
African-American patients with chronic obstructive pulmonary disease, or COPD, are less likely to participate in pulmonary rehabilitation programs than white patients, even when there are programs nearby.

COPD and type 2 diabetes
COPD and type 2 diabetes are two highly prevalent global health conditions associated with high mortality and morbidity.

Read More: COPD News and COPD Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.